An Equilar news release said overall CFO pay increased despite a 3.4% retreat in median bonus payouts, but were buoyed by an 8.2% increase in median total equity compensation.In 2007, S&P 500 CFOs received a median aggregate bonus of $576,880, down from the median of $597,263 in 2006.
Additionally, the prevalence of CFOs receiving bonus compensation fell from 99% in 2006 to 93.6% in 2007, Equilar said.
According to the study, the median base salary for S&P 500 CFOs increased by 9.1%, from $481,250 to $525,000 from 2006 to 2007.
The executive compensation study covered 313 S&P 500 CFOs in place for at least two years.
For companies disclosing two consecutive years of compensation data under the new Securities and Exchange Commission disclosure rules trends included:
- Among S&P 500 CFOs receiving discretionary bonuses, the median value of payouts fell by 2.7% from 2006 to 2007. Similarly, the prevalence of discretionary payouts declined from 29.7% in 2006 to 26.2% in 2007.
- In 2007, S&P 500 CFOs received a median annual cash bonus of $455,571. This amount was 2% less than the median annual cash bonus of $465,000 in 2006.
- Among S&P 500 CFOs in long-term incentive plans, the median value of long-term cash bonus payouts rose by 16.7% from 2006 to 2007, to a median of $455,571 in 2007, versus $390,229 in 2006.
- From 2006 to 2007, the total value of equity awards for S&P 500 CFOs increased 8.2%, from a median of $1,408,804 in 2006 to a median of $1,523,810 in 2007.
- In 2007, CFOs at S&P 500 companies received stock awards with a median value of $785,970 an increase of 16.1% over the median grant of $676,807 in 2006.
- Contrary to trends observed for chief executives, from 2006 to 2007, the median value of S&P 500 CFO option awards increased by 7%.
- In 2007, the median value of accumulated pension benefits for S&P 500 CFOs was $1,061,198, an increase of 17.7% over the median of $901,524 in 2006.
- The median value of deferred compensation plan balances increased by 21.3% from 2006 to 2007, climbing to $779,388.
To learn more about these findings, please visit www.equilar.com or call 1-877-441-6090.